FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

ALEMBICLTD

121
-1.7 (-1.39%)
Updated 12:20 30/07 IST

ALEMBICLTD Buy or Sell - FrontPage Forums

2 Users have submitted 2 trade ideas of Rs. 36,069 for ALEMBICLTD
Disclaimer
100% Bullish
0% Bearish

ALEMBICLTD Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See ALEMBICLTD Share Price Targets >>

ALEMBICLTD Ratings

Long term ALEMBICLTD rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live ALEMBICLTD message board: Is ALEMBICLTD buy or sell? Should I buy ALEMBICLTD shares? Why are ALEMBICLTD shares falling? Should I invest in ALEMBICLTD stock?

  1. Home
  2. ALEMBICLTD Forum

ALEMBICLTD Share Price Discussion

T
Reputation: 152 • Just now
Like
Reply
Like
Reply
N
Reputation: 15,707 • Jul 27 10:01 AM
Market Movers: Why Dr Reddy’s fell & took other drug stocks down with it
The biggest trigger for the nose bleeding fall in Dr Reddy's Labs stock was hidden away in the notes to account of the companys P&L statement.
The Economic Times
1
Reply
N
Reputation: 15,707 • Jul 26 1:36 AM
Blackstone India ex-MD Neeraj Mohan joins EY-Parthenon
Worked for about 10 years with Blackstone India, Neeraj Mohan had been involved in Blackstones investments in Aadhar Housing Finance, Comstar Automotive Technologies, Gateway Rail Freight, International Tractors, NCC Limited, and SONA BLW Limited. He currently serves on the boards of Comstar Automotive and Aadhar Housing Finance.
The Economic Times
Like
Reply
2
Reputation: 0 • Jul 20 5:08 AM

Type
Buy
Instrument
ALEMBICLTD
Entry Price
₹130
Price@Trade
₹130.7
Target Price
₹150
Stop Price
₹121
Valid Till
Aug 20, 2021 3:20 AM
Margin
₹130 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹121
Net P&L
-₹9 (-6.92%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 20 8:45 AM

Update
Trade Entered
Entry Price
₹130
TrackerBot @trackerbot
Jul 27 6:47 AM

Update
Stoploss Hit
Exit Price
₹121
Like
Reply

Type
Buy
Instrument
ALEMBICLTD
Entry Price
₹137.7
Price@Trade
₹137.7
Target Price
₹155
Stop Price
₹126.9
Valid Till
Aug 18, 2021 3:20 AM
Margin
₹49,572 approx for 360 Qty
Status
Exited
Exit Price
₹130.2
Net P&L
-₹2,700 (-5.45%)
Like
Reply (1)
swap_vert
Trade
See all replies

Update
Exited
Exit Price
₹130.2
Net P&L
-₹2,700 (-5.45%)
Like
Reply (1)
See all replies

139.35
M
Reputation: 0 • Jul 16 3:42 AM

Type
Buy
Instrument
ALEMBICLTD
Entry Price
₹135
Price@Trade
₹135.45
Target Price
₹145
Stop Price
₹125
Valid Till
Aug 16, 2021 3:20 AM
Margin
₹67,500 approx for 500 Qty
Status
Stoploss Hit
Exit Price
₹125
Net P&L
-₹5,000 (-7.41%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 16 6:09 AM

Update
Trade Entered
Entry Price
₹135
TrackerBot @trackerbot
Jul 27 4:33 AM

Update
Stoploss Hit
Exit Price
₹125
V
Reputation: 1,563 • Jul 15 8:29 AM
VishwaSK in ALEMBICLTD
#ALEMBICLTD buy 131 sl 127.50 tgt 139 / 148
Like
Reply
V
Reputation: 1,563 • Jul 15 3:35 AM
Like
Reply
2
Reputation: 0 • Jul 13 8:14 AM

Type
Buy
Instrument
ALEMBICLTD
Entry Price
₹126
Price@Trade
₹126
Target Price
₹140
Stop Price
₹119  ₹126
Valid Till
Aug 13, 2021 3:20 AM
Margin
₹31,500 approx for 250 Qty
Status
Exited
Exit Price
₹133
Net P&L
+₹1,750 (+5.56%)
Like
Reply (2)
swap_vert
Trade
See all replies
219656 @219656
Jul 15 3:23 AM

Update
Stoploss Trailed
Price @ Update
₹132.4
Original SL
₹119
New SL
126.0
219656 @219656
Jul 15 3:26 AM

Update
Exited
Exit Price
₹133
Net P&L
+₹1,750 (+5.56%)

Type
Buy
Instrument
ALEMBICLTD
Entry Price
₹128.5  ₹129.05
Price@Trade
₹128.85
Target Price
₹129.5
Stop Price
₹127.5
Valid Till
Jul 12, 2021 3:20 AM
Margin
₹25,810 approx for 200 Qty
Status
Target Achieved
Exit Price
₹129.5
Net P&L
+₹90 (+0.35%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 12 3:56 AM

Update
Trade Entered
Entry Price
₹129.05
TrackerBot @trackerbot
Jul 12 4:21 AM

Update
Target Achieved
Exit Price
₹129.5
N
Reputation: 15,707 • Jul 8 7:26 AM
Alembic Pharmaceuticals gets USFDA nod for anti-depressant drug
The approved product is therapeutically equivalent to the reference listed drug product Norpramin tablets of Validus Pharmaceuticals LLC.
The Economic Times
Like
Reply
Like
Reply
Like
Reply
A
Reputation: 0 • Jul 6 3:52 AM

Type
Buy
Instrument
ALEMBICLTD
Entry Price
₹126.65  ₹126.8
Price@Trade
₹126.8
Target Price
₹150
Stop Price
₹120
Valid Till
Jul 13, 2021 3:20 AM
Margin
₹101,440 approx for 800 Qty
Status
Exited
Exit Price
₹129.7
Net P&L
+₹2,320 (+2.29%)

Like
Reply (3)
swap_vert
Trade
See all replies
Amal @amal-BJTuQ2Kv_
Jul 6 3:53 AM

Update
Entry Price Modified
Price @ Update
₹126.7
Original Entry Price
₹126.65
New Entry Price
126.8
TrackerBot @trackerbot
Jul 6 3:53 AM

Update
Trade Entered
Entry Price
126.8
Amal @amal-BJTuQ2Kv_
Jul 7 3:34 AM

Update
Exited
Exit Price
₹129.7
Net P&L
+₹2,320 (+2.29%)
A
Reputation: 0 • Jul 6 3:37 AM

Type
Buy
Instrument
ALEMBICLTD
Entry Price
₹127.6  ₹127.2
Price@Trade
₹127.3
Target Price
₹150
Stop Price
₹120
Valid Till
Jul 13, 2021 3:20 AM
Margin
₹25,440 approx for 200 Qty
Status
Exited
Exit Price
₹129.7
Net P&L
+₹500 (+1.97%)

Like
Reply (3)
swap_vert
Trade
See all replies
Amal @amal-BJTuQ2Kv_
Jul 6 3:37 AM

Update
Entry Price Modified
Price @ Update
₹127.2
Original Entry Price
₹127.6
New Entry Price
127.2
TrackerBot @trackerbot
Jul 6 3:38 AM

Update
Trade Entered
Entry Price
127.2
Amal @amal-BJTuQ2Kv_
Jul 7 3:34 AM

Update
Exited
Exit Price
₹129.7
Net P&L
+₹500 (+1.97%)
R
Reputation: 32 • Jul 1 5:02 AM
Like
Reply
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • ALEMBICLTD - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization1,084.98
    Enterprise Value1,082.99
    Price to Earnings34.72
    Price to Book Value2.6
    Return on Capital Employed0.12
    Return on Equity0.12
    Face Value2
    Dividend YieldNA
  • ALEMBICLTD Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 29126126.85121.45122.7
    Jul 28124.4126.3122.5125.85
    Jul 27129.95130.75120.4124.3
    Jul 26130.4131.8128.9129.2
    Jul 23131.1134.75129.5129.9
  • ALEMBICLTD Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹128.61
    30 Day Moving Average₹128.89
    50 Day Moving Average₹129.24
    100 Day Moving Average₹119.63
    200 Day Moving Average₹109.99
  • ALEMBICLTD - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue125144.26-0.13
    Operating Profit110.9111.09
    Profit Before Tax4426.630.65
    Net Income4127.490.49
  • ALEMBICLTD - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds4183460.21
    Total Liabilities58181-0.68
    Total Assets476528-0.1
  • ALEMBICLTD - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity2351.63-0.55
    Cash from Investing Activity-22-46.69-0.53
    Cash from Financing Activity-2-4.96-0.6
    Net Cash Flow-1-0.0249
  • ALEMBICLTD - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.080.06
    Return on Equity0.120.07
    Return on Capital Employed0.120.07
  • ALEMBICLTD - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.13
    3 Year CAGR Growth in Operating Profit0.11
    3 Year CAGR Growth in EBIDTA0.52
    3 Year CAGR Growth in Net Income0.7
    3 Yr CAGR Growth - Diluted EPS0.71
  • ALEMBICLTD - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.3
    5 Year CAGR Growth in Operating Profit-0.3
    5 Year CAGR Growth in EBIDTA0.77
    5 Year CAGR Growth in Net Income2.57
    3 Yr CAGR Growth - Diluted EPS0.79
  • ALEMBICLTD - Recent News

    keyboard_arrow_down
    NewsBot
    Jul 27 10:01 AM
    Market Movers: Why Dr Reddy’s fell & took other drug stocks down with it
    The Economic Times
    NewsBot
    Jul 26 1:36 AM
    Blackstone India ex-MD Neeraj Mohan joins EY-Parthenon
    The Economic Times
    NewsBot
    Jul 8 7:26 AM
    Alembic Pharmaceuticals gets USFDA nod for anti-depressant drug
    The Economic Times
    NewsBot
    Jun 17 10:51 AM
    Government takes steps to enhance availability of Amphotericin B; 6.67 lakh vials allocated to states so far
    The Economic Times
    NewsBot
    May 14 7:56 AM
    Alembic Pharma gets USFDA nod for bipolar depression drug
    The Economic Times
    NewsBot
    Feb 10 12:46 PM
    Alembic, Mphasis, Granules and 3 others in F&O
    The Economic Times
    NewsBot
    Jan 19 1:31 AM
    Stocks in the news: Adani Green, YES Bank, ICICI Lombard & Mindtree
    The Economic Times
    NewsBot
    Oct 16, 2020 6:11 AM
    Alembic Pharma gets USFDA nod for anti-viral drug
    The Economic Times
    NewsBot
    Aug 14, 2020 6:13 AM
    Amrutanjan Heal Standalone June 2020 Net Sales at Rs 46.62 crore, up 4.54% Y-o-Y
    Moneycontrol
    NewsBot
    Jun 19, 2020 3:23 AM
    Amrutanjan Heal Standalone March 2020 Net Sales at Rs 59.29 crore, down 31.03% Y-o-Y
    Moneycontrol
  • ALEMBICLTD - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020